COIN Fellows
COIN Fellows
-
Madeline Frost, PhD, MPH
- Title: VA HSR Advanced PhD Fellow
- Contact: madeline.frost@va.gov
- Location: Seattle
- See Dr. Frost's Dimensions profile that includes: publications, grants, datasets, patents and clinical trials
Dr. Frost is a Health Systems Research and Development Fellow. She earned her PhD and MPH degrees from the Department of Health Systems and Population Health in the University of Washington School of Public Health. Her research primarily focuses on expanding access to and improving the quality of substance use treatment and harm reduction services.
She is particularly interested in the implementation of substance use-related care in primary care and various specialty care settings, as well as improving this care for patients with comorbid conditions. She has been conducting this work in the VA for several years and is excited to continue working in a learning healthcare system that is dedicated to translating research findings into improved care for the Veteran population.
Recent Publications
2024
Briggs ES, Thomas RM, Frost MC, Fletcher OV, Crothers K, Chalal CK, Shahrir SF, McClure JB, Catz SL, Williams EC. "I Thought Cancer was a Tobacco Issue": Perspectives of Veterans with and without HIV on Cancer and Other Health Risks Associated with Alcohol and Tobacco/Nicotine Use. AIDS Behav. 2024 Jun 13. doi: 10.1007/s10461-024-04363-6. Epub ahead of print.
PMID: 38869757
Bachrach RL, Frost MC, Fletcher OV, Chen JA, Chinman M, Ellis R, Williams EC. Receipt of Medications for Alcohol Use Disorder in the Veterans Health Administration: Comparison of Rates at the Intersections of Racialized and Ethnic Identity With Both Sex and Transgender Status. J Addict Med. 2024 Jun 6. doi: 10.1097/ADM.0000000000001323. Epub ahead of print.
PMID: 38842176
Frost MC, Coughlin LN, Zhang L, Lin LA. Comparison of Treatment Receipt and Hospitalization Among Patients With Stimulant Use Disorder and/or Opioid Use Disorder in the Veterans Health Administration. J Addict Med. 2024 Jun 4. doi: 10.1097/ADM.0000000000001329. Epub ahead of print.
PMID: 38832683
Coughlin LN, Zhang L, Frost MC, Khazanov G, McKay JR, DePhilippis D, Lin LA. Contingency management for substance use disorders in the U.S. Veterans Health Administration: 2018-2022. J Subst Use Addict Treat. 2024 May 10:209400. doi: 10.1016/j.josat.2024.209400. Epub ahead of print.
PMID: 38735480
Williams EC, Frost MC, Bounthavong M, Edmonds AT, Lau MK, Edelman EJ, Harvey MA, Christopher MLD. Implementation of Opioid Safety Efforts: Influence of Academic Detailing on Adverse Outcomes Among Patients in the Veterans Health Administration. Subst Use Addctn J. 2024 Apr 18:29767342241243309. doi: 10.1177/29767342241243309. Epub ahead of print.
PMID: 38634339
Perumalswami PV, Adams MA, Frost MC, Holleman R, Kim HM, Zhang L, Lin LA. Telehealth and delivery of alcohol use disorder treatment in the Veterans Health Administration. Alcohol Clin Exp Res (Hoboken). 2024 Mar 26. doi: 10.1111/acer.15305. Epub ahead of print.
PMID: 38529689
Williams EC, Frost MC, Danner AN, Lott AMK, Achtmeyer CE, Hood CL, Malte CA, Saxon AJ, Hawkins EJ. "The Only Reason I Am Willing to Do It at All": Evaluation of VA's SUpporting Primary care Providers in Opioid Risk reduction and Treatment (SUPPORT) Center. J Addict Med. 2024 Feb 22. doi: 10.1097/ADM.0000000000001277. Epub ahead of print.
PMID: 38385548
Soyer EM, Frost MC, Fletcher OV, Ioannou GN, Tsui JI, Edelman EJ, Weiner BJ, Bachrach RL, Chen JA, Williams EC. Perspectives of clinical stakeholders and patients from four VA liver clinics to tailor practice facilitation for implementing evidence-based alcohol-related care. Addict Sci Clin Pract. 2024 Jan 10;19(1):3. doi: 10.1186/s13722-023-00429-3. PMCID: PMC10782537.
PMID: 38200496
Learn more about this publication at Dimensions
2023
Williams EC, Frost MC, Lodi S, Forman LS, Lira MC, Tsui JI, Lunze K, Kim T, Liebschutz JM, Rio CD, Samet JH. Influence of patient trust in provider and health literacy on receipt of guideline-concordant chronic opioid therapy in HIV care settings. J Opioid Manag. 2023 Sep-Oct;19(5):385-393. doi: 10.5055/jom.0812.
PMID: 37968972
Learn more about this publication at Dimensions
Frost MC, Malte CA, Hawkins EJ, Glass JE, Hallgren KA, Williams EC. Impact of an intervention to implement provision of opioid use disorder medication among patients with and without co-occurring substance use disorders. J Subst Use Addict Treat. 2023 Sep 24:209175. doi: 10.1016/j.josat.2023.209175. Epub ahead of print.
PMID: 37751798
Learn more about this publication at Dimensions
Coughlin LN, Frost MC, Zhang L, Lin LA. Impact of COVID-19 on stimulant use disorder treatment: A national cohort study in the Veterans Health Administration. Drug Alcohol Depend. 2023 Sep 20;252:110965. doi: 10.1016/j.drugalcdep.2023.110965. Epub ahead of print.
PMID: 37769514
Learn more about this publication at Dimensions
Frost MC, Soyer EM, Achtmeyer CE, Hawkins EJ, Glass JE, Hallgren KA, Williams EC. Treating opioid use disorder in veterans with co-occurring substance use: a qualitative study with buprenorphine providers in primary care, mental health, and pain settings. Addict Sci Clin Pract. 2023 May 4;18(1):26. doi: 10.1186/s13722-023-00382-1. PMCID: PMC10157128.
PMID: 37143162
Learn more about this publication at Dimensions
Perumalswami PV, Kilpatrick S, Frost MC, Adams MA, Kim HM, Zhang L, Lin L. The impact of COVID-19 on trends in alcohol use disorder treatment in Veterans Health Administration. Addiction. 2023 Feb 3. doi: 10.1111/add.16156. Epub ahead of print.
PMID: 36738085
Learn more about this publication at Dimensions
2022
Frost MC, Zhang L, Kim HM, Lin LA. Use of and Retention on Video, Telephone, and In-Person Buprenorphine Treatment for Opioid Use Disorder During the COVID-19 Pandemic. JAMA Netw Open. 2022 Oct 3;5(10):e2236298. doi: 10.1001/jamanetworkopen.2022.36298. PMCID: PMC9557869.
PMID: 36223118
Learn more about this publication at Dimensions
Frost MC, Hawkins EJ, Glass JE, Hallgren KA, Williams EC. Associations Between Distinct Co-occurring Substance Use Disorders and Receipt of Medications for Opioid Use Disorder in the Veterans Health Administration. J Addict Med. 2022 Oct 18. doi: 10.1097/ADM.0000000000001095. Epub ahead of print.
PMID: 36255116
Learn more about this publication at Dimensions
Austin EJ, Corcorran MA, Briggs ES, Frost MC, Behrends CN, Juarez AM, Frank ND, Healy E, Prohaska SM, LaKosky PA, Kapadia SN, Perlman DC, Schackman BR, Jarlais DCD, Williams EC, Glick SN. Barriers to engaging people who use drugs in harm reduction services during the COVID-19 pandemic: A mixed methods study of syringe services program perspectives. Int J Drug Policy. 2022 Aug 10;109:103825. doi: 10.1016/j.drugpo.2022.103825. Epub ahead of print. PMCID: PMC9364718.
PMID: 35977459
Learn more about this publication at Dimensions
Corcorran MA, Austin EJ, Behrends CN, Briggs ES, Frost MC, Juarez AM, Frank ND, Healy E, Prohaska SM, LaKosky PA, Kapadia SN, Perlman DC, Schackman BR, Des Jarlais DC, Williams EC, Glick SN. Syringe Service Program Perspectives on Barriers, Readiness, and Programmatic Needs to Support Rollout of the COVID-19 Vaccine. J Addict Med. 2022 Aug 2. doi: 10.1097/ADM.0000000000001036. Epub ahead of print.
PMID: 35916422
Learn more about this publication at Dimensions
Frost MC, Austin EJ, Corcorran MA, Briggs ES, Behrends CN, Juarez AM, Frank ND, Healy E, Prohaska SM, LaKosky PA, Kapadia SN, Perlman DC, Schackman BR, Des Jarlais DC, Williams EC, Glick SN. Responding to a surge in overdose deaths: perspectives from US syringe services programs. Harm Reduct J. 2022 Jul 19;19(1):79. doi: 10.1186/s12954-022-00664-y. PMCID: PMC9295104.
PMID: 35854351
Learn more about this publication at Dimensions
Fletcher OV, Chen JA, van Draanen J, Frost MC, Rubinsky AD, Blosnich JR, Williams EC. Prevalence of social and economic stressors among transgender veterans with alcohol and other drug use disorders. SSM Popul Health. 2022 Jun 28;19:101153. doi: 10.1016/j.ssmph.2022.101153. PMCID: PMC9260617.
PMID: 35813187
Learn more about this publication at Dimensions
Williams EC, Fletcher OV, Frost MC, Harris AHS, Washington DL, Hoggatt KJ. Comparison of Substance Use Disorder Diagnosis Rates From Electronic Health Record Data With Substance Use Disorder Prevalence Rates Reported in Surveys Across Sociodemographic Groups in the Veterans Health Administration. JAMA Netw Open. 2022 Jun 1;5(6):e2219651. doi: 10.1001/jamanetworkopen.2022.19651.
PMID: 35771574
Learn more about this publication at Dimensions
Frost MC, Richards JE, Blosnich JR, Hawkins EJ, Tsui JI, Edelman EJ, Williams EC. Association between clinically recognized suicidality and subsequent initiation or continuation of medications for opioid use disorder. Drug Alcohol Depend. 2022 Jun 3;237:109521. doi: 10.1016/j.drugalcdep.2022.109521. Epub ahead of print.
PMID: 35716644
Learn more about this publication at Dimensions
Matson TE, Harris AHS, Chen JA, Edmonds AT, Frost MC, Rubinsky AD, Blosnich JR, Williams EC. Influence of a national transgender health care directive on receipt of alcohol-related care among transgender Veteran Health Administration patients with unhealthy alcohol use. J Subst Abuse Treat. 2022 May 24:108808. doi: 10.1016/j.jsat.2022.108808. Epub ahead of print.
PMID: 35715286
Learn more about this publication at Dimensions
Frost MC, Matson TE, Richards JE, Lee AK, Achtmeyer CE, Bradley KA, Williams EC. Barriers and facilitators to changing drinking and receiving alcohol-related care: Interviews with Veterans Health Administration primary care patients who indicated interest but did not enroll in an alcohol care management intervention trial. Subst Abus. 2022;43(1):1197-1206. doi: 10.1080/08897077.2022.2074602.
PMID: 35657656
Learn more about this publication at Dimensions
2021
Beckman KL, Williams EC, Hebert PL, Frost MC, Rubinsky AD, Hawkins EJ, Littman AJ, Lehavot K. Associations Among Military Sexual Trauma, Opioid Use Disorder, and Gender. Am J Prev Med. 2021 Nov 3:S0749-3797(21)00505-5. doi: 10.1016/j.amepre.2021.08.020. Epub ahead of print.
PMID: 34742619.
Frost MC, Lampert H, Tsui JI, Iles-Shih MD, Williams EC. The impact of methamphetamine/amphetamine use on receipt and outcomes of medications for opioid use disorder: a systematic review. Addict Sci Clin Pract. 2021 Oct 11;16(1):62. doi: 10.1186/s13722-021-00266-2. PMCID: PMC8504567.
PMID: 34635170.
Williams EC, Chen JA, Frost MC, Rubinsky AD, Edmonds AT, Glass JE, Lehavot K, Matson TE, Wheat CL, Coggeshall S, Blosnich JR. Receipt of evidence-based alcohol-related care in a national sample of transgender patients with unhealthy alcohol use: Overall and relative to non-transgender patients. J Subst Abuse Treat. 2021 Jul 8:108565. doi: 10.1016/j.jsat.2021.108565. Epub ahead of print.
PMID: 34274175.
Frost MC, Sweek EW, Austin EJ, Corcorran MA, Juarez AM, Frank ND, Prohaska SM, LaKosky PA, Asher AK, Broz D, Jarlais DCD, Williams EC, Glick SN. Program Adaptations to Provide Harm Reduction Services During the COVID-19 Pandemic: A Qualitative Study of Syringe Services Programs in the U.S. AIDS Behav. 2021 Jun 10:1–12. doi: 10.1007/s10461-021-03332-7. Epub ahead of print. PMCID: PMC8190167.
PMID: 34110506.
Williams EC, Frost MC, Rubinsky AD, Glass JE, Wheat CL, Edmonds AT, Chen JA, Matson TE, Fletcher OV, Lehavot K, Blosnich JR. Patterns of Alcohol Use Among Transgender Patients Receiving Care at the Veterans Health Administration: Overall and Relative to Nontransgender Patients. J Stud Alcohol Drugs. 2021 Jan;82(1):132-141.
PMID: 33573731.
